HC Wainwright Issues Pessimistic Estimate for ENTA Earnings
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA – Free Report) – Investment analysts at HC Wainwright dropped their Q2 2025 earnings estimates for Enanta Pharmaceuticals in a report released on Tuesday, February 11th. HC Wainwright analyst E. Arce now expects that the biotechnology company will post earnings per share of ($1.42) for the quarter, down from their previous […]
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA – Free Report) – Investment analysts at HC Wainwright dropped their Q2 2025 earnings estimates for Enanta Pharmaceuticals in a report released on Tuesday, February 11th. HC Wainwright analyst E. Arce now expects that the biotechnology company will post earnings per share of ($1.42) for the quarter, down from their previous […]
